Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07399314

Evaluating the Effectiveness of a School-based Stepped Care Treatment Model for Adolescent Depression in Pakistan

Conditions: Depression Anxiety Disorder, Psychological Distress, Well-Being, Psychological

Sex: All
Ages: 13 Years – 15 Years
Healthy volunteers: No
Phase: NA
Enrollment: 600
Sponsor: Global Institute of Human Development

Location: Global Institute of Human Development Islamabad Punjab Province

Summary

This study aims to test the effectiveness of a stepped-care model to reduce depressive symptoms in adolescents in school settings in Pakistan. The study will examine whether the universal intervention, delivered by non-specialists, can reduce depressive symptoms in adolescents after 3 months. For adolescents who do not improve with universal intervention, the study will assess whether a Cognitive Behavioural Therapy (CBT)-based guided self-help app can provide additional support as a second-step intervention. Six hundred adolescents aged 13-15 from 40 schools in Rawalpindi, Pakistan, will take part. The study will determine which interventions work best and for which students to reduce depressive symptoms in school settings in Pakistan.

Eligibility Criteria

Inclusion Criteria: 1. Adolescents aged 13-15 years, currently enrolled in participating schools 2. Provide assent for participation 3. Parental/guardian consent provided 4. Screen positive for psychosocial distress on the youth-reported Pediatric Symptom Checklist (PSC), defined as a total score ≥ 28 Exclusion Criteria: 1. Adolescents who require immediate in-patient (medical and/or psychiatric) care 2. Adolescents with acute protection risks as assessed by a researcher applying the definitions in the WHO mhGAP intervention guide.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07399314). StuddyBuddy aggregates publicly available trial information.